# Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC)

> **NCT03493997** · PHASE2 · COMPLETED · sponsor: **Study Group for Urogenital Diseases, Italy** · enrollment: 100 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **COMBINATION_PRODUCT:** Radiotherapy+IAluril®+Ialuril Soft Gels®
- **RADIATION:** Radiotherapy only

## Key facts

- **NCT ID:** NCT03493997
- **Lead sponsor:** Study Group for Urogenital Diseases, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-04
- **Primary completion:** 2018-10-31
- **Final completion:** 2020-05-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493997, "Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03493997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*